Zobrazeno 1 - 10
of 60
pro vyhledávání: '"R C Moellering"'
Publikováno v:
Antimicrobial agents and chemotherapy. 57(9)
The killing activity of daptomycin against an isogenic pair of daptomycin-susceptible and daptomycin-nonsusceptible (DNS) methicillin-resistant Staphylococcus aureus (MRSA) strains was enhanced by the addition of certain cell wall agents at 1× MIC.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ccd1b8e3082ff684eda6d52828eed14d
https://pubmed.ncbi.nlm.nih.gov/23796933
https://pubmed.ncbi.nlm.nih.gov/23796933
Publikováno v:
Antimicrobial Agents and Chemotherapy. 39:850-853
This study evaluated the in vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agent. The drug inhibited all tested members of the family Enterobacteriaceae at < or = 0.5 microgram/ml and all tested Pseudomonas aeruginosa, Burkholderia (Ps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9857527a7c515ad09ee5295012b18eeb
https://doi.org/10.1128/aac.39.4.850
https://doi.org/10.1128/aac.39.4.850
Publikováno v:
Antimicrobial Agents and Chemotherapy. 39:990-995
The in vitro activity of a prototype 2-aryl carbapenem, L-695,256, against gram-positive bacteria was examined. All streptococci and oxacillin-susceptible and -resistant staphylococci were inhibited at concentrations of < or = 0.125, < or = 0.125, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7c37ca21979556d3481ca65e3129eae
https://doi.org/10.1128/aac.39.4.990
https://doi.org/10.1128/aac.39.4.990
Publikováno v:
The Journal of antimicrobial chemotherapy. 44(2)
A progressive increase in the incidence of vancomycin resistance in strains of Enterococcus faecium (VREF) has severely constrained treatment options for patients with infection caused by this emerging pathogen. Quinupristin/dalfopristin (Synercid),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4eea42329c5296d149174001d58c2bff
https://pubmed.ncbi.nlm.nih.gov/10473233
https://pubmed.ncbi.nlm.nih.gov/10473233
Autor:
R C, Moellering
Publikováno v:
European journal of clinical microbiologyinfectious diseases : official publication of the European Society of Clinical Microbiology. 17(6)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6bd616a8d959f481bce7c87efb23abd3
https://pubmed.ncbi.nlm.nih.gov/9758282
https://pubmed.ncbi.nlm.nih.gov/9758282
Autor:
R C, Moellering, P K, Linden
Publikováno v:
The American journal of medicine. 104(5A)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::baa6047e4838a2325eb31911a95889b5
https://pubmed.ncbi.nlm.nih.gov/9684650
https://pubmed.ncbi.nlm.nih.gov/9684650
Autor:
R C, Moellering
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 26(5)
The development of antimicrobial resistance has almost invariably accompanied the therapeutic use of antimicrobial agents. Newer antimicrobials have succeeded partly but not entirely in overcoming the problem of resistance. Antimicrobial resistance i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a6dff57fa0b5577e782e0309abd023da
https://pubmed.ncbi.nlm.nih.gov/9597248
https://pubmed.ncbi.nlm.nih.gov/9597248
Publikováno v:
Antibiotics and chemotherapy. 47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5bfb2b8eae0f39a8f16d3a9aee6e922b
https://pubmed.ncbi.nlm.nih.gov/8554301
https://pubmed.ncbi.nlm.nih.gov/8554301
Autor:
R C, Moellering
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 18(4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a06bd57e1b72782cea040ea2d96abec2
https://pubmed.ncbi.nlm.nih.gov/8038307
https://pubmed.ncbi.nlm.nih.gov/8038307